Anzeige
Mehr »
Donnerstag, 26.02.2026 - Börsentäglich über 12.000 News
Während Washington Kupfer strategisch erklärt, schärft diese Aktie ihr Modell
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von MassDevice

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
17.02.Danaher reportedy nears $10B deal to buy Masimo
17.02.European Commission ends Edwards antitrust probe after company withdraws anti-copycat policy
16.02.VB Spine to acquire Augmedics' augmented reality navigation tech
13.02.Profusa, Mayo Clinic collab on oxygen monitoring tech
13.02.Medtronic wins FDA nod for surgical robot for spine procedures
13.02.Philips introduces flexible pediatric MRI coil
13.02.Siemens Healthineers, Mayo Clinic collab to treat neurodegenerative disease
13.02.Structural heart treatment developer BioVentrix files for IPO
12.02.Dexcom beats Street in Q4 on 13% sales growth
12.02.Kandu trial highlights positive outcomes with IpsiHand BCI system
12.02.Valcare announces first transseptal implantation of Amend annuloplasty system in U.S.
12.02.Encora wins FDA clearance for wearable device for essential tremor
12.02.Baxter stock dives on Q4 EPS miss, company introduces new operating model
12.02.Karl Storz, Smith+Nephew partner on advanced surgical tech
12.02.Stryker says DOJ, SEC have closed bribery probes
12.02.Novocure wins FDA nod for Optune Pax as pancreatic cancer treatment
11.02.Outset Medical stock dips on Q4 EPS miss
11.02.Resmed launches AirTouch F30i Comfort full-face fabric mask
11.02.LifeScan, i-SENS partner to launch CGM platform
11.02.Stryker launches T2 Alpha humerus nailing system, expands trauma nailing portfolio
11.02.Neurent raises $74M to accelerate chronic rhinitis treatment launch
11.02.BVI completes first U.S. implants of trifocal IOL
11.02.Philips Seismic consortium picks up $28M for next-gen brain treatments
11.02.Sentante robot tech for treating stroke accepted into FDA TAP program
11.02.Edwards Lifesciences misses EPS estimate by $0.04, surpasses revenue prediction